Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol/Midazolam for ICU Sedation
NCT00226785Phase 3Terminated
- Sponsor
- Orion Corporation
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dexmedetomidine in conscious sedation, sponsored by Orion Corporation. Started Oct 2005; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
conscious sedation
Beyond the preview
Go deeper on NCT00226785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226785.